Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Journal of Molecular Endocrinology|August 14, 2003
Genomic structure and transcriptional regulation of the human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase geneA Nandy, S Jenatschke, B Hartung, et al.
The Biochemical Journal|January 12, 1999
Biochemical characterization of a variant human medium-chain acyl-CoA dehydrogenase with a disease-associated mutation localized in the active siteB Küchler, A G Abdel-Ghany, P Bross, et al.
Biochemistry|September 24, 1996
Crystal structures of the wild type and the Glu376Gly/Thr255Glu mutant of human medium-chain acyl-CoA dehydrogenase: influence of the location of the catalytic base on substrate specificityH J Lee, M Wang, R Paschke, et al.
Indian Journal of Public Health|July 2, 1999
Resurgence of malaria in Calcutta in 1995: a hospital based studyK Basu, P K Das, T Mondal, et al.
Tropical Medicine & International Health : TM & IH|March 4, 1998
Recurrence of kala-azar after PKDL: role of co-factorsA Nandy, M Addy, A K Maji, et al.
Tropical Medicine and Parasitology : Official Organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft Fur Technische Zusammenarbeit (GTZ)|June 1, 1995
Pathogenicity of Artyfechinostomum oraoni in naturally infected pigsA K Bandyopadhyay, A K Maji, B Manna, et al.
The Indian Journal of Medical Research|September 1, 1995
Studies on the life cycle of Artyfechinostomum oraoni Bandyopadhyay, Manna & Nandy 1989: embryogenesis & development in the intermediate hostA K Maji, B Manna, A K Bandyopadhyay, et al.
Tropical Medicine & International Health : TM & IH|April 1, 1997
Laryngeal involvement during post kala-azar dermal leishmaniasis in IndiaA Nandy, M Addy, D Banerjee, et al.
Human Vaccines & Immunotherapeutics|April 13, 2012
Dynamics of the antibodies in cohorts of cured cases of visceral leishmaniasis: its implication on the validity of serological test, value in prognosis and in post therapeutic assessmentRajan R Patil, Jayaparakash P Muliyil, A Nandy, et al.
International Archives of Allergy and Immunology|October 4, 2007
Characterization of a hypoallergenic recombinant Bet v 1 variant as a candidate for allergen-specific immunotherapyH Kahlert, R Suck, B Weber, et al.
Pageof 11